Importantly, ERBB2 can be deregulated by other mutations, namely missense in other regions, and harbor gene amplification mechanisms,6, 8 which were not explored in the present study, and could lead to a higher percentage of ERRB2 genomic alterations in Brazilian lung cancer patients. The gene discussed is ERBB2; the disease is lung cancer.